Cosimo Commisso: Can a Stroma-Sensing TGF-β Inhibitor Transform Cancer Immunotherapy?
Cosimo Commisso/LinkedIn

Cosimo Commisso: Can a Stroma-Sensing TGF-β Inhibitor Transform Cancer Immunotherapy?

Cosimo Commisso, Professor and Deputy Director, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, shared on LinkedIn:

“In mouse models of pancreatic and breast cancer, a stroma-sensing TGF-β inhibitor developed by a team led by senior author Seong-Jin Kim blocks TGF-β signaling selectively within the tumor, reprogramming CAF-myeloid niches and enabling T cell infiltration into desmoplastic tumors.

T cell-derived interferon-gamma then shifts the surrounding stromal and myeloid compartments toward an immune-permissive state, producing tumor clearance, reduced metastasis in breast cancer, and durable immune memory.”

Read The Full Article.

Title: A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity

Authors: Dong Woo Kang, Jin Beom Bae, Seonho Yoo, Hyejin Kim, Pyunggang Kim, Jaewoo Mo, Jinhwan Kim, Jin Su Kim, Kwiyeom Yoon, Ye Seon Kim, Jeong Su Lee, June Myoung Kim, Min Gi Kang, Min Jung Lee, Changwon Lim, Isaac Y. Kim, Chang Pyo Hong, Junil Kim, John J. Letterio, Seong-Jin Kim.

You may also be interested in: